Similar articles

• The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.

  Dabrowski A, Gabryelewicz A. Dabrowski A, et al. J Physiol Pharmacol. 1994 Sep;45(3):455-65. J Physiol Pharmacol. 1994. PMID: 7841457
• Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.

  Lankisch PG, Pohl U, Göke B, Otto J, Wereszczynska-Siemiatkowska U, Gröne HJ, Rahlf G. Lankisch PG, et al. Gastroenterology. 1989 Jan;96(1):193-9. doi: 10.1016/0016-5085(89)90780-4. Gastroenterology. 1989. PMID: 2909420
• [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].

  Freise J. Freise J. Fortschr Med. 1983 Aug 25;101(31-32):1432-6. Fortschr Med. 1983. PMID: 6194089 German.
• [Clinical study of chronic pancreatitis].

  Yamamoto Y. Yamamoto Y. Nihon Naika Gakkai Zasshi. 1993 Mar 10;82(3):401-5. Nihon Naika Gakkai Zasshi. 1993. PMID: 8315335 Review. Japanese. No abstract available.
• [Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].

  Ohkoshi M. Ohkoshi M. Gan To Kagaku Ryoho. 1995 Mar;22(4):417-30. Gan To Kagaku Ryoho. 1995. PMID: 7887633 Review. Japanese.